Scpharmaceuticals Stock Analysis

Scpharmaceuticals Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.91. Scpharmaceuticals had not issued any dividends in recent years. scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. To find out more about Scpharmaceuticals contact John Tucker at 617 517 0730 or learn more at https://www.scpharmaceuticals.com.

Scpharmaceuticals Investment Alerts

Scpharmaceuticals Upcoming and Recent Events

Scpharmaceuticals Largest EPS Surprises

View All Earnings Estimates

Scpharmaceuticals Environmental, Social, and Governance (ESG) Scores

Scpharmaceuticals Stock Institutional Investors

Note, although Scpharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Scpharmaceuticals Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 150.85 M.

Scpharmaceuticals Profitablity

The company has Profit Margin (PM) of (2.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.35) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.35.

Management Efficiency

Scpharmaceuticals has return on total asset (ROA) of (0.4009) % which means that it has lost $0.4009 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.3697) %, meaning that it created substantial loss on money invested by shareholders. Scpharmaceuticals' management efficiency ratios could be used to measure how well Scpharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.83. The Scpharmaceuticals' current Return On Capital Employed is estimated to increase to -0.66. As of now, Scpharmaceuticals' Other Current Assets are increasing as compared to previous years. The Scpharmaceuticals' current Debt To Assets is estimated to increase to 0.51, while Total Assets are projected to decrease to under 93.4 M.

Technical Drivers

As of the 24th of March, Scpharmaceuticals has the Coefficient Of Variation of (4,838), variance of 7.45, and Risk Adjusted Performance of (0.01). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scpharmaceuticals, as well as the relationship between them.

Scpharmaceuticals Price Movement Analysis

Scpharmaceuticals Insider Trading Activities

Scpharmaceuticals Outstanding Bonds

Scpharmaceuticals Predictive Daily Indicators

Scpharmaceuticals Corporate Filings

Scpharmaceuticals Forecast Models

Scpharmaceuticals' time-series forecasting models are one of many Scpharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Scpharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Scpharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Scpharmaceuticals shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Scpharmaceuticals. By using and applying Scpharmaceuticals Stock analysis, traders can create a robust methodology for identifying Scpharmaceuticals entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Scpharmaceuticals analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Scpharmaceuticals analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Scpharmaceuticals stock analysis indicators help investors evaluate how Scpharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Scpharmaceuticals shares will generate the highest return on investment. By understating and applying Scpharmaceuticals stock analysis, traders can identify Scpharmaceuticals position entry and exit signals to maximize returns.

When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.